George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThrogmorton Trust Regulatory News (THRG)

Share Price Information for Throgmorton Trust (THRG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 589.00
Bid: 587.00
Ask: 589.00
Change: 6.00 (1.03%)
Spread: 2.00 (0.341%)
Open: 588.00
High: 590.00
Low: 587.00
Prev. Close: 583.00
THRG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Portfolio Update

16 Sep 2016 16:47

BLACKROCK THROGMORTON TRUST PLC - Portfolio Update

BLACKROCK THROGMORTON TRUST PLC - Portfolio Update

PR Newswire

London, September 16

BLACKROCK THROGMORTON TRUST PLC All information is at 31 August 2016 and unaudited.
Performance at month end is calculated on a cum income basis
One Month %Three months %One year %Three years %Five years %
Net asset value (undiluted)#4.41.35.638.0105.8
Net asset value (fully diluted)4.41.35.638.0100.2
Share price5.1-0.80.329.799.1
Benchmark*2.6 2.73.625.671.4
Sources: BlackRock and Datastream #Prior to dilution arising on conversion of subscription shares. *With effect from 1 December 2013 the Numis Smaller Companies excluding AIM (excluding investment companies) Index replaced the Numis Smaller Companies plus AIM (excluding investment companies) Index as the Company’s benchmark. The three and five year period indices have been blended to reflect this. 
At month end
Net asset value capital only:392.29p
Net asset value incl. income:396.79p
Share price328.00p
Discount to cum income NAV17.3%
Net yield2.1%*
Total Gross assets£290.2m**
Net market exposure as a % of net asset value^106.0%
Ordinary shares in issue:73,130,326*** 
2015 ongoing charges (excluding performance fees):1.1%****
2015 ongoing charges (including performance fees):2.3%
* Calculated using current year interim dividend and prior year final dividend. ** Includes current year revenue and excludes the gross exposure through contracts for difference. *** Excluding 7,400,000 shares held in treasury. **** Calculated as a percentage of average net assets and using expenses, excluding performance fees and interest costs for the year ended 30 November 2015. ^Long positions less short positions as a percentage of net asset value.
Sector Weightings% of Total Assets
Industrials31.2
Consumer Services20.4
Financials14.5
Consumer Goods9.0
Technology7.7
Health Care6.7
Basic Materials6.5
Oil & Gas2.0
Net current assets2.0
-----
Total100.0
=====
Market Exposure (Quarterly)
30.11.15 %29.02.16 %31.05.16 %31.08.16 %
Long115.2118.2114.4114.3
Short9.211.28.38.3
Gross exposure124.4129.4122.7122.6
Net exposure106.0107.0106.1106.0
Ten Largest Investments
Company% of Total Gross Assets
4imprint Group3.2
CVS Group3.1
Dechra Pharmaceuticals2.6
JD Sports2.3
Hill & Smith2.2
Fevertree Drinks1.8
Accesso Technology1.8
Savills1.8
Workspace Group1.8
Restore1.7

Commenting on the markets, Mike Prentis and Dan Whitestone, representing the Investment Manager noted:During August the Company’s NAV per share rose by 4.4% on a cum income basis whilst our benchmark index rose by 2.6%; the FTSE 100 Index rose by 1.7%.

The long only portfolio increased in value by 4.2%, outperforming the benchmark by 1.6%. The CFD portfolio added 0.1% to performance. Long CFDs added 0.5% to NAV whilst short CFDs detracted 0.4%.

Outperformance in the long only portfolio was largely driven by stock selection with our large holdings in 4imprint Group and CVS Group contributing well. 4imprint announced half year results which showed revenues up by 17%, all organic, 19% increase in earnings per share and net cash of $20m. 96% of 4imprint revenue is generated in the USA. Trading patterns in the first half are expected to continue into the second half. CVS put out a year end trading update which indicated results were expected to be modestly ahead of market expectations. Like-for-like revenues were up 4.8% for the year to 30 June, up from a more normal 3.0% in the first half. CVS has continued to be acquisitive adding 67 surgeries in the year taking its total surgeries operated to 360.

There were no long only portfolio holdings which were significant detractors from relative performance from a stock specific point of view during the month.

Sector allocation made a small position contribution helped by both our underweight position in mining stocks and our overweight position in housing related stocks.

During the month we added a number of small holdings in the long only portfolio including Ultra Electronics, Coats, Dairy Crest and Costain. Ultra and Coats both generate the majority of their revenues internationally. Ultra is more confident of seeing a return to organic sales growth and defence budgets are generally looking better underpinned. Coats is benefitting from the growth of the Asian consumer, although it is a truly global business. Dairy Crest should benefit from higher cheese profits and the growth of its demineralised whey business. Costain should benefit from increasing infrastructure spending. 

Turning to the CFD portfolio, August proved quite a challenging month, particularly for the short book in light of the market rally and also the overall shape of the market. Despite that backdrop, the CFD portfolio was still able to deliver a positive return, but it felt hard work! The Long CFD book benefitted from some strong stock specifics, notably CVS Group, 4Imprint Group, Balfour Beatty and MicroFocus. The enduring benefits of Sterling weakness, combined with the monetary policy response we’ve witnessed has helped fuel a “risk-on” rally, which has negatively impacted areas of the short book which dragged on performance. Overall, we’ve not made too many changes to the portfolio, but have tactically increased exposure to UK housebuilders and construction related activities in the long book in the hope that the lever of fiscal policy is used with greater effect going forward to stimulate economic growth. 

16 September 2016

ENDS

Latest information is available by typing www.blackrock.co.uk/thrg on the internet, "BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV terminal). Neither the contents of the Manager’s website nor the contents of any website accessible from hyperlinks on the Manager’s website (or any other website) is incorporated into, or forms part of, this announcement.

Date   Source Headline
26th Apr 20245:36 pmPRNTransaction in Own Shares
26th Apr 202411:42 amPRNNet Asset Value(s)
26th Apr 20247:00 amPRNTotal Voting Rights
25th Apr 20246:00 pmPRNTransaction in Own Shares
25th Apr 20245:45 pmPRNDirector/PDMR Shareholding
25th Apr 202412:11 pmPRNNet Asset Value(s)
25th Apr 20247:00 amPRNTotal Voting Rights
24th Apr 20245:54 pmPRNTransaction in Own Shares
24th Apr 202412:11 pmPRNNet Asset Value(s)
24th Apr 20247:00 amPRNTotal Voting Rights
23rd Apr 20245:41 pmPRNTransaction in Own Shares
23rd Apr 202412:11 pmPRNNet Asset Value(s)
23rd Apr 20247:00 amPRNTotal Voting Rights
22nd Apr 20245:52 pmPRNTransaction in Own Shares
22nd Apr 202411:52 amPRNNet Asset Value(s)
22nd Apr 20247:00 amPRNTotal Voting Rights
19th Apr 20246:00 pmPRNTransaction in Own Shares
19th Apr 202412:05 pmPRNNet Asset Value(s)
19th Apr 20247:00 amPRNTotal Voting Rights
18th Apr 20246:36 pmPRNTransaction in Own Shares
18th Apr 202412:14 pmPRNNet Asset Value(s)
18th Apr 20247:00 amPRNTotal Voting Rights
17th Apr 20245:58 pmPRNTransaction in Own Shares
17th Apr 202412:12 pmPRNNet Asset Value(s)
17th Apr 20247:00 amPRNTotal Voting Rights
16th Apr 20245:45 pmPRNTransaction in Own Shares
16th Apr 202412:00 pmPRNNet Asset Value(s)
16th Apr 20247:00 amPRNTotal Voting Rights
15th Apr 20245:54 pmPRNTransaction in Own Shares
15th Apr 202411:34 amPRNNet Asset Value(s)
15th Apr 20247:00 amPRNTotal Voting Rights
12th Apr 20246:50 pmPRNTransaction in Own Shares
12th Apr 202412:32 pmPRNDirector/PDMR Shareholding
12th Apr 202412:12 pmPRNNet Asset Value(s)
12th Apr 20247:00 amPRNTotal Voting Rights
11th Apr 20245:55 pmPRNTransaction in Own Shares
11th Apr 20245:51 pmPRNDirector/PDMR Shareholding
11th Apr 202412:08 pmPRNNet Asset Value(s)
11th Apr 20247:00 amPRNTotal Voting Rights
10th Apr 20245:33 pmPRNTransaction in Own Shares
10th Apr 202412:02 pmPRNNet Asset Value(s)
10th Apr 20247:00 amPRNTotal Voting Rights
9th Apr 20246:06 pmPRNTransaction in Own Shares
9th Apr 20245:02 pmPRNDirector/PDMR Shareholding
9th Apr 202411:43 amPRNNet Asset Value(s)
9th Apr 20247:00 amPRNTotal Voting Rights
8th Apr 20246:33 pmPRNHolding(s) in Company
8th Apr 20246:15 pmPRNTransaction in Own Shares
8th Apr 202411:56 amPRNNet Asset Value(s)
8th Apr 20247:00 amPRNTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.